Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%24.82x1.66x3.61x12.09x13.71x 30.84B
0.57%0.65%17.84x2.03x3.86x10.13x11.56x 69.07B
0.62%0.63%25.52x3.85x5.27x15.47x19.18x 51.77B
-.--%-.--%34.53x6.94x11.71x22.37x26.07x 43.63B
3.34%3.43%-45.77x2.51x3.23x9.55x11.15x 40.89B
-.--%-.--%-7.29x4.42x10.33x-6.35x-5.96x 25.06B
-.--%-.--%41.68x - - - - 23.3B
-.--%0.05%68.08x6.12x6.73x46.32x52.25x 20.92B
-.--%-.--%24.41x3.5x5.19x13.22x18.57x 16.71B
-.--%-.--%-36.59x-6.4x17.25x-47.16x-54.34x 15.74B
-.--%-.--%-114.9x12555.08x12.35x-88.4x-123.26x 12.2B
-.--%-.--%17.7x - 3.64x14.09x15.9x 11.6B
-.--%-.--%45.1x - - - - 10.08B
0.18%0.19%50.59x20.63x30.53x43.18x44.53x 10B
2.84%3.22%12.04x1.08x1.81x7.29x9.85x 6.29B
0.35%0.4%29.87x - 8.06x21.39x25.54x 6.1B
1.59%1.76%14.22x1.31x2.5x6.48x7.84x 5.71B
-.--%-.--%-113.6x - - - - 5.58B
Average 0.53% 0.57% 4.90x 969.44x 8.40x 5.31x 4.84x 22.53B
Weighted average by Cap. 0.59% 0.63% 11.02x 442.52x 7.16x 8.89x 9.81x
Biopharmaceuticals